Actively Recruiting
ONO-4538 Phase II Rollover Study (ONO-4538-98)
Led by Ono Pharmaceutical Co., Ltd. · Updated on 2025-06-03
59
Participants Needed
38
Research Sites
329 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is intended to confirm the long-term safety of ONO-4538 in pan-tumor participants being treated with ONO-4538 monotherapy or in Combination with Other Therapies in clinical trials.
CONDITIONS
Official Title
ONO-4538 Phase II Rollover Study (ONO-4538-98)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants currently treated with ONO-4538 alone or in combination with other therapies in clinical trials
- Participants eligible for ONO-4538 monotherapy or combination therapy based on clinical trials or investigator-assessed benefit
You will not qualify if you...
- Participants unable to provide consent due to conditions such as dementia
- Participants deemed inappropriate for this study by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 38 locations
1
Chiba Clinical Site1
Kashiwa, Chiba, Japan
Actively Recruiting
2
Ehime Clinical Site1
Matsuyama, Ehime, Japan
Completed
3
Fukuoka Clinical Site1
Kurume, Fukuoka, Japan
Actively Recruiting
4
Hokkaido Clinical Site1
Sapporo, Hokkaido, Japan
Actively Recruiting
5
Hyogo Clinical Site1
Akashi, Hyōgo, Japan
Actively Recruiting
6
Kanagawa Clinical Site1
Yokohama, Kanagawa, Japan
Actively Recruiting
7
Oita Clinical Site1
Yufu, Oita Prefecture, Japan
Actively Recruiting
8
Osaka Clinical Site1
Suita, Osaka, Japan
Actively Recruiting
9
Osaka Clinical Site3
Takatsuki, Osaka, Japan
Actively Recruiting
10
Saitama Clinical Site1
Hidaka, Saitama, Japan
Actively Recruiting
11
Saitama Clinical Site2
Kitaadachi-gun, Saitama, Japan
Actively Recruiting
12
Tokyo Clinical Site3
Bunkyo-ku, Tokyo, Japan
Actively Recruiting
13
Tokyo Clinical Site2
Chuo-ku, Tokyo, Japan
Actively Recruiting
14
Tokyo Clinical Site1
Koto-ku, Tokyo, Japan
Actively Recruiting
15
Tokyo Clinical Site4
Shinjuku-ku, Tokyo, Japan
Actively Recruiting
16
Chiba Clinical Site2
Chiba, Japan
Actively Recruiting
17
Fukuoka Clinical Site2
Fukuoka, Japan
Actively Recruiting
18
Fukuoka Clinical Site3
Fukuoka, Japan
Actively Recruiting
19
Hiroshima Clinical Site1
Hiroshima, Japan
Actively Recruiting
20
Kyoto Clinical Site1
Kyoto, Japan
Actively Recruiting
21
Okayama Clinical Site1
Okayama, Japan
Actively Recruiting
22
Osaka Clinical Site2
Osaka, Japan
Actively Recruiting
23
Daegu Clinical Site1
Daegu, South Korea
Actively Recruiting
24
Gyeonggi-do Clinical site1
Gyeonggi-do, South Korea
Actively Recruiting
25
Incheon Clinical Site1
Incheon, South Korea
Actively Recruiting
26
Seoul Clinical Site1
Seoul, South Korea
Actively Recruiting
27
Seoul Clinical Site2
Seoul, South Korea
Completed
28
Seoul Clinical Site3
Seoul, South Korea
Actively Recruiting
29
Seoul Clinical Site4
Seoul, South Korea
Actively Recruiting
30
Seoul Clinical Site5
Seoul, South Korea
Actively Recruiting
31
Seoul Clinical Site6
Seoul, South Korea
Actively Recruiting
32
Kaohsiung Clinical Site1
Kaohsiung City, Taiwan
Completed
33
Kaohsiung Clinical Site2
Kaohsiung City, Taiwan
Completed
34
Tainan Clinical Site1
Tainan, Taiwan
Actively Recruiting
35
Tainan Clinical Site2
Tainan, Taiwan
Actively Recruiting
36
Taipei Clinical Site1
Taipei, Taiwan
Actively Recruiting
37
Taipei Clinical Site2
Taipei, Taiwan
Actively Recruiting
38
Taoyuan Clinical Site1
Taoyuan, Taiwan
Actively Recruiting
Research Team
N
North America Clinical Trial Support Desk
CONTACT
I
International Clinical Trial Support Desk
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here